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Abstract: Background: Clinical rating systems are used as outcome 
measures in clinical trials and attempt to gauge the patient's views of 
their own health. The choice of clinical rating system should be 
supported by its performance against established quality standards.  
 
Methods: A search strategy was developed to identify all studies 
reporting the use of clinical rating systems in the tennis elbow 
literature. The strategy was run from inception in Medline Embase and 
CINHAL. Data extraction identified the date of publication, country of 
data collection, pathology assessed and outcome measure used. 
 
Results: 980 studies were identified that reported clinical rating system 
use. 72 separate rating systems were identified. 41% of studies used two 
or more separate measures. Overall 54% of studies used the Mayo Elbow 
Performance Score (MEPS). For Arthroplasty 82% used MEPS, 17% used 
Disabilities of Arm, Shoulder and Hand (DASH), 7% used quickDASH. For 
Trauma 66.7% used MEPS, 32% used DASH, 23% used the Morrey Score. For 
Tendinopathy, 31% used DASH, 23% used Patient-Rated Tennis Elbow 
Evaluation, 13% used MEPS. Over time there is increased proportional use 
of the MEPS, DASH, qDASH, Patient Rated Tennis Elbow Evaluation (PRTEE) 
and Oxford Elbow Score (OES).  
 
Conclusions: This study has identified the wide choice and usage of 
clinical rating systems in the elbow literature. Numerous studies report 
measures without a history of either pathology specific or cross-cultural 
validation. Interpretability and comparison of outcomes is dependent on 
the unification of outcome measure choice. This is not currently 
demonstrated. 
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Abstract  1 
Clinical Rating Systems in Elbow Research –  2 
A Systematic Review Exploring Trends and Distributions of Use  3 
 4 
Background: Clinical rating systems are used as outcome measures in clinical trials and 5 
attempt to gauge the patient’s views of their own health. The choice of clinical rating system 6 
should be supported by its performance against established quality standards.  7 
Methods: A search strategy was developed to identify all studies reporting the use of clinical 8 
rating systems in the tennis elbow literature. The strategy was run from inception in Medline 9 
Embase and CINHAL. Data extraction identified the date of publication, country of data 10 
collection, pathology assessed and outcome measure used. 11 
Results: 980 studies were identified that reported clinical rating system use. 72 separate 12 
rating systems were identified. 41% of studies used two or more separate measures. Overall 13 
54% of studies used the Mayo Elbow Performance Score (MEPS). For Arthroplasty 82% 14 
used MEPS, 17% used Disabilities of Arm, Shoulder and Hand (DASH), 7% used 15 
quickDASH. For Trauma 66.7% used MEPS, 32% used DASH, 23% used the Morrey Score. 16 
For Tendinopathy, 31% used DASH, 23% used Patient-Rated Tennis Elbow Evaluation, 13% 17 
used MEPS. Over time there is increased proportional use of the MEPS, DASH, qDASH, 18 
Patient Rated Tennis Elbow Evaluation (PRTEE) and Oxford Elbow Score (OES).  19 
Conclusions: This study has identified the wide choice and usage of clinical rating systems 20 
in the elbow literature. Numerous studies report measures without a history of either 21 
pathology specific or cross-cultural validation. Interpretability and comparison of outcomes is 22 
dependent on the unification of outcome measure choice. This is not currently demonstrated. 23 
  24 
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Background 25 
 The ultimate measure of success in health care is whether it helps patients as they see 26 
it 
[8]
. In an effort to capture the effect of health interventions on patients, there has been a 27 
considerable investment of resources by academics and clinicians to develop systematic, 28 
robust and valid ways of collecting health data from patients 
[24]
.  It is now the current 29 
standard that treatment evaluation includes the use of clinical rating systems 
[52]
.  30 
 Current clinical rating systems in elbow research utilize both physician and patient 31 
completed measures. They aggregate various attributes of interest such as elbow pain, range 32 
of motion and ability to perform specific tasks 
[46]
. Though there was a historical focus on 33 
physician-administered tools, recent emphasis has been on the patient-rated outcome 34 
measurement (PROM), whereby information is gathered pertaining to the patients’ perception 35 
of their elbow function 
[52]
. 36 
 The rise in the use of clinical rating systems has accompanied a fundamental shift in 37 
how we measure health. Traditional measurements of treatment effect, such as length of 38 
hospital stay, radiographic markers or range of motion, are increasingly accompanied by, or 39 
indeed replaced by rating systems, with a particular emphasis on PROMs 
[24]
. In the United 40 
States, the Food and Drug Administration (FDA) recommends the use of PROMs in clinical 41 
trials 
[10]
. Within the UK, the use of PROMs is commonplace in assessing the effectiveness 42 
and cost-effectiveness of healthcare technologies 
[40]
. Furthermore, the UK’s National 43 
PROMs programme 
[56]
 has led the world in the standardized collection of PROMs for hip 44 
and knee arthroplasty.  45 
 The increasing popularity of patient-focused outcome measurement has accompanied 46 
a consequent rise in the production of numerous rating systems. When choosing the 47 
appropriate rating system, to be applied to either clinical or research purposes, it is necessary 48 
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to identify existing systems that measure the outcome of interest in the target population 
[58]
. 49 
To aid in this selection, databases such as ePROVIDE (https://eprovide.mapi-trust.org/) 50 
catalog potential rating systems, though by their own admission, their database is supplied 51 
exponentially with new tools.  52 
 Careful consideration must be given to the selection of the clinical rating system. An 53 
appropriate measure should be supported by published evidence demonstrating that it is 54 
acceptable to patients, reliable, valid and responsive (sensitive to change) 
[18]
. Furthermore, 55 
these properties should have been tested on similar reference groups of patients to those being 56 
studied, thereby ensuring the validity of a tool from a language and cultural perspective 
[2]
. 57 
Within the domain of orthopedics, particular emphasis has been placed on the use of clinical 58 
rating systems for particular anatomical locations (predominantly joints) rather than generic 59 
health measures. More recently this has evolved to concentrate on condition-specific tools, 60 
where, in certain groups or in certain conditions, generic or region specific tools miss 61 
important aspects of health status 
[24]
. For the appropriate interpretation, it is, therefore, vital 62 
that the clinical rating system selected is validated for use in the population of interest and for 63 
the specific condition being investigated.  64 
 Heterogeneity of outcome selection has been reported in systematic reviews of elbow 65 
related controlled trials where there is consistent comment that this heterogeneity hampers 66 
effective evidence synthesis 
[12, 14, 34]
. Initiatives to combat this include the Core Outcome 67 
Measures in Effectiveness Trials (COMET) and the U.S. National Institutes of Health (NIH) 68 
Patient Reported Outcomes Measurement Information System (PROMIS®), who aim to 69 
bring standardization to outcome measure selection. By adopting common standards and 70 
metrics clinical researchers will be able to directly compare patients’ evaluations of 71 
interventional effects across countries, thereby increasing the relevance of results and 72 
enabling International syntheses (such as meta-analyses) of research findings 
[2]
.  73 
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 Systematic reviews assessing elbow-specific clinical rating systems have concluded 74 
that a paucity of quality measures exist 
[21, 30, 52, 53]
. The most recent review by The et al 
[52]
 75 
included the assessment of 12 rating systems using the Consensus-Based Standards for the 76 
Selection of health Measurement Instruments (COSMIN) checklist, the authors conclude that 77 
the Oxford Elbow Score (OES) is the only system that has been developed using high-quality 78 
methodology.  79 
 The distribution of use of elbow-specific rating systems across different elbow 80 
pathologies is not known. Riedel et al 
[46]
 reviewed 65 articles, which used elbow specific 81 
aggregate scores specifically in elbow arthroplasty published between 2004 - 2011. They 82 
report the predominant use of the Mayo Elbow Performance score in 75% of the literature 83 
they identified. They criticise the use of this physician administered score that was not 84 
developed with a formal methodology and is frequently inconsistently applied. 85 
 This study aims to assess the use of clinical rating systems in elbow related 86 
interventional studies. The assessment of the appropriation of rating systems to specific 87 
elbow pathologies and across populations has not been undertaken. Furthermore, the change 88 
in trends of use over time, with the recent increased emphasis on PROMs use, has not been 89 
evaluated. Only when armed with the knowledge of either the conformity or heterogeneity of 90 
rating systems, can compelling arguments be made for the need for standardization.    91 
 92 
 93 
 94 
 95 
 96 
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Method 97 
A comprehensive review of elbow specific clinical rating systems in the elbow literature was 98 
conducted. This review aimed to identify all articles reporting the use of both physician and 99 
patient-reported rating systems. Both rating systems designed specifically for use in elbow 100 
pathology and generic upper limb rating systems with a history of validation and in elbow 101 
pathology were included.  The presented report has been written following PRISMA 102 
guidelines
[35]
. A search strategy was constructed using MeSH and free-text terms (appendix 103 
1). 104 
The strategy was modeled to each database through the modification of thesaurus terms, 105 
wildcards, and truncation. The search was run on 1
st
 May 2017 in Medline (Ovid MEDLINE, 106 
1948 to 2016 & Ovid MEDLINE In-Process & Non-indexed Citations) accessed through 107 
OVIDSP, Embase (Embase 1974 to 2017) accessed through OVIDSP and CINHAL 108 
(CINHAL 1981 to 2017) accessed through EBSCO host. 109 
The search strategy development was guided by previously published search strategies for 110 
systematic reviews of interventions in elbow pathology 
[11]
 and for the identification of 111 
outcome measures 
[26]
, along with terms specifically selected in order to capture names of 112 
relevant instruments published in previous systematic reviews of elbow specific rating scales 113 
[21, 30, 52, 53]
. 114 
The review was conducted in a step-wise manner. At each stage, dual review was employed 115 
with the lead author and a further co-author reviewer. In cases of disagreement between 116 
reviewers, the article proceeded to the next stage of review to ensure maximum sensitivity. 117 
Initial title review was used to exclude duplicates, studies in pediatric populations, non-elbow 118 
based studies, case-reports, case-studies, surgical technique papers and conference abstracts. 119 
Abstract review used the above criteria and also excluded studies that did not report the use 120 
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of rating systems designed specifically for elbow measurement, or generic rating systems 121 
with no history of validation in elbow measurement.  122 
Data extraction was conducted by JE and NF. Publication date, geographical location of lead 123 
author or publishing institution, elbow pathology investigated and elbow specific clinical 124 
rating systems reported was extracted.  125 
The elbow specific pathology or intervention of interest was grouped into the following 126 
categories for ease of interpretation: arthritis interventions (non-arthroplasty), arthroplasty 127 
(trauma and elective), arthroscopy, distal biceps intervention, neuropathy intervention, sports-128 
specific population, tendinopathy (non-sports specific population) and trauma interventions 129 
(non-arthroplasty).   130 
References were retrieved and imported into reference management software (Endnote X7, © 131 
2017 Clarivate Analytics, PA, USA). Database management was conducted in Excel 132 
(Microsoft® Excel® 2013, Redmond, WA, USA).  133 
 134 
 135 
 136 
 137 
 138 
 139 
 140 
 141 
 142 
Clinical Rating Systems in Elbow Research 
 
7 
 
Results 143 
The review identified 980 articles reporting the use of elbow-specific clinical rating systems 144 
(fig 1). Articles from 52 countries were included.  72 separate instruments were identified 145 
(appendix 2).  146 
The 980 articles reported the use of 1383 outcomes. 322 (32%) of articles reported the use of 147 
two separate elbow-specific clinical rating systems, 77 (8%) reported the use of three, 4 148 
(0.4%) reported the use of four separate elbow-specific clinical rating systems.  149 
The number of articles reporting elbow specific rating systems has increased over time (fig 2) 150 
reaching 106 published articles in 2016.  151 
Overall, from database inception, the Mayo Elbow Performance (MEP) score was reported in 152 
54% of articles, the Disabilities of Arm Shoulder and Hand (DASH) in 29%, the Morrey 153 
Score 12%, the abbreviated DASH (quickDASH) in 8%, the Patient-Rated Tennis Elbow 154 
Evaluation (PRTEE) in 5%, the American Shoulder and Elbow Society-Elbow score (ASES-155 
e) in 4%, the Oxford Elbow Score (OES) in 4%. All other scores were reported in less than 156 
2% of articles.  157 
Since 2000 and 2010 respectively, the proportionate use within the literature for the above 158 
rating systems are: MEPS 55% & 61%, DASH 30% & 34%, Morrey 12% & 9%, quickDASH 159 
9% & 13%, PRTEE 5% & 7%, ASES-e 4% & 3%, and OES 4% & 6% (fig 3). 160 
The top five clinical rating systems for the individual pathology or intervention group are 161 
outlined in fig 13. 162 
For the three largest groups; arthroplasty, tendinopathy, and trauma, the most popular clinical 163 
rating systems are further grouped by time periods; database inception, since 2000 and since 164 
2010 (table 1). 165 
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Geographic distribution is shown in table 2, with data grouped into three broad localities; 166 
North America, Europe, and Rest of the World.  167 
 168 
 169 
 170 
 171 
 172 
 173 
 174 
 175 
 176 
 177 
 178 
 179 
 180 
 181 
 182 
 183 
 184 
 185 
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Discussion 186 
The elbow has long been thought of as the forgotten joint, with pathologies that are difficult 187 
to treat and surgical procedures that carry higher complication rates than any other major 188 
joint 
[7]
. However, modern diagnostic and treatment practices have shown great promise, and 189 
clinical effectiveness research has sought to accurately quantify the benefits patients are 190 
experiencing. In keeping with modern research reporting practice, the ultimate goal has been 191 
to demonstrate the ability of an intervention to restore or preserve functioning and well-being 192 
related to health, that is health-related quality of life (HRQoL) 
[42]
.  193 
This study has demonstrated that the use of elbow-related clinical rating systems, that aim, in 194 
some form, to demonstrate patient related benefit following an intervention, is rapidly 195 
expanding year on year. Though previously published systematic reviews of elbow rating 196 
systems have highlighted the deficits in many of the tools 
[30-32, 52]
, trend data have failed to 197 
show large shifts in choice towards tools produced with high quality methodology.  198 
Global data across pathologies and interventions of 980 articles have identified the Mayo 199 
Elbow Performance Score (MEPS) Score as the predominant rating system. The MEPS was 200 
developed by Morrey and Adams in 1992 
[37]
, for outcome assessment in total elbow 201 
arthroplasty. It consists of a physician assessment of pain, arc of motion and stability, with a 202 
patient rating of daily function. It has a history of validation in elective elbow surgery 203 
patients with mixed pathology
[17, 19]
, arthroplasty 
[37]
, trauma 
[38]
 and rheumatoid arthritis 
[21]
. 204 
Assessment under the COSMIN checklist rated all its development and validation domains as 205 
fair to poor 
[52]
. The Disabilities of Arm Shoulder and Hand (DASH) is also commonly 206 
employed. This patient-reported outcome measure (PROM) was introduced in 1996 
[28]
. It 207 
consists of a 31 core item questionnaire with 8 additional questions for sport and work 208 
assessment. It was designed to evaluate the entire upper limb but has a history of validation in 209 
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elbow-specific pathology including; arthrolysis 
[27]
, arthroplasty 
[6, 5]
, lateral epicondylar 210 
tendinopathy 
[3, 13, 29, 39, 41, 47, 50, 55]
, rheumatoid arthritis 
[44]
, neuropathy 
[33, 59]
, elective elbow 211 
surgery 
[17, 19, 25, 49]
, biceps tendon repair and radial head post-surgery 
[57]
. It has not 212 
undergone systematic evaluation and head to head comparison with other elbow-specific 213 
rating systems using recognized techniques such as COSMIN 
[36]
 or EMPRO 
[54]
. Of the other 214 
scores, large heterogenicity of application was demonstrated, astoundingly 72 separate 215 
instruments were identified across the literature, since 2010, 45 of these separate instruments 216 
are continuing to be used.   217 
Assessment of the use of rating systems in the predefined criteria groups showed some 218 
element of preference for specially designed scales. Neuropathy, sports specific population, 219 
and tendinopathy groups showed the utilization of scores specifically designed for population 220 
or pathology use. Examples include the Dellon score 
[23]
 in neuropathy, Andrews-Carson 221 
score 
[4]
 in sports population and the Patient-Rated Tennis Elbow Evaluation (PRTEE)
[47]
 in 222 
the tendinopathy group. Of note, within all the above-mentioned groups and distal biceps 223 
group, the DASH score remains the first or second score of preference.  224 
The three largest subgroups were assessed for a change of rating scale use over time. The 225 
recent emergence and promotion of patient-rated over physician-rated evaluation would lead 226 
most to the hypothesis of increased proportional representation within these groups over time. 227 
Within all groups, the use of DASH and quickDASH is rising, the tendinopathy group also 228 
demonstrated a particular emergence of the PRTEE. Yet, whilst the Morrey and HSS are 229 
declining in use, of interest is the progressive rise of the MEPS across all groups.  230 
Trends in rating-systems in differing geographical areas since 2010 was also assessed. 231 
Though the sub-division of areas is rather crude, this sub-division yielded groups of a size 232 
substantial enough to interpret broad distribution trends. The MEPS, though developed in the 233 
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USA, has a higher total proportion of use in Europe and Rest of the World groups. The 234 
MEPS has only been formally assessed for cross-cultural validity in Turkish 
[16]
 
[15]
 UK 235 
English 
[17, 19]
 and Dutch 
[20]
. The DASH score is proportionally more popular in North 236 
America, though it has been cross-culturally adapted to multiple languages. Interestingly, the 237 
abbreviated quickDASH is twice as commonly employed in Europe when compared to the 238 
USA. Again the quickDASH is available in multiple languages, but it is important to note 239 
that in terms of elbow-specific cross-cultural adaptation and validation, this has only been 240 
conducted in Turkish, Italian and Dutch 
[3, 22, 25]
.  241 
Standardization of outcome evaluation, together with consensus in the scientific community, 242 
is an essential component of the future of comparative effectiveness research. Only then will 243 
we be able to compare results between different groups, hospitals, and protagonists 
[51]
. The 244 
shift in focus from physician to patient-reported outcomes is well documented, with support 245 
both within the literature and from a governmental/health service level 
[1]
. Within elbow 246 
specific literature Dawson et al 
[17]
 reported that patient-reported results are more likely than 247 
clinically assessed outcome measures to reflect patient satisfaction with elbow surgery. 248 
Furthermore, they also provide support that condition-specific measures are more likely than 249 
generic measures to be more closely aligned with patient satisfaction.  Yet, we have shown 250 
that within the literature there remains a persistent reticence to embrace PROMs more fully. 251 
As Snyder et al 
[48]
 comment, though PROMs have the potential to improve the quality of 252 
patient-centeredness medical care, there is a great deal of research to be done before they are 253 
fully embraced by all stakeholders. Within elbow-specific literature, it may be the consensus 254 
that the literature is, as yet, uncompelling and lacking clear recommendations. Recent review 255 
evidence, that systematically assess the development and psychometric properties of elbow 256 
specific rating systems, has only emerged since 2013 
[46, 52]
 and it may be that the trickle-257 
down effect may simply not have been felt. 258 
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It is vitally important to recognize that inappropriate rating system choice can have a great 259 
impact on the interpretation of results, particularly where they are used as the primary 260 
endpoint in clinical studies 
[52]
. The choice of a rating system should be optimally aligned 261 
with a conceptual framework that defines the health condition and will meet the performance 262 
requirements of the clinical context and measurement needs 
[32]
. Therein, a score developed 263 
for the elbow may not be valid across all populations and all pathologies. Quantification of 264 
health-related quality of life in an elderly rheumatoid arthritis patient undergoing total elbow 265 
arthroplasty may require an evaluation of very different domains to a middle-aged manual 266 
laborer with tennis elbow. The clinical rating scale must have demonstrated its validity, 267 
reliability, responsiveness, and interpretability for the pathology being investigated to justify 268 
its choice. This must also be the case for the population of question where the cross-cultural 269 
validation of an outcome measures is a vital component in ensuring its interpretability, with 270 
clearly described methodological and reporting requirements 
[45]
. Consequently, for example, 271 
an American developed measure in the English language, does not have automatic validity in 272 
other English speaking populations.  273 
The future of clinical rating systems in elbow pathology is fluctuating with the same 274 
uncertainty that pervades the whole orthopedic research community. Though we have 275 
identified numerous rating scales, new measures continue to be produced. Though this 276 
highlights the expanding, and exciting, growth in this field, where there are multiple choices, 277 
this can lead to greater uncertainty and create barriers to uptake 
[9]
. The use of registries may 278 
force some level of conformity in data collection. In the UK the National PROMs programme 279 
has collected Oxford hip and knee scores since 2009. With the inclusion of elbow 280 
arthroplasty into the National Joint Registry in 2012, it remains likely that an outcome 281 
measure will be added to this dataset. The use of PROMIS (Patient-Reported Outcome 282 
Measurement Information System), to provide a set of common metrics to which PROMs that 283 
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assess comparable constructs can be scaled 
[9]
, has shown great utility, but has not been 284 
applied to elbow pathology 
[43]
.  285 
The authors accept that this study has limitations. As with all systematic reviews, this study is 286 
limited by the search strategy used, however, considerable care was taken to produce a 287 
strategy that was as sensitive as possible. The subclassifications of data into pathology and 288 
population groups were derived to give the best impression possible of rating scale use. The 289 
use of arthroplasty, for example, was kept as a single group, though a case can be made that 290 
rheumatoid and trauma patients may respond differently and require different rating systems, 291 
under the recommendations outlined above.  Equally, the trauma group could easily be 292 
further sub-classified. However, we feel that the strength of the data is the representation of 293 
the three large sub-classification groups.   294 
 295 
 296 
 297 
 298 
 299 
 300 
 301 
 302 
 303 
 304 
 305 
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Conclusion 306 
This study is the first to identify the true magnitude of choice of clinical rating systems for 307 
the elbow. From 980 manuscripts we identified 72 individual clinical rating systems. Though 308 
we are seeing a small advance in the use of validated condition-specific PROMs, such as the 309 
PRTEE, the overwhelming key players in outcome measurements remain the historic or 310 
generic measures, such as the MEPS and DASH score. The co-administration of multiple 311 
scores may be seen as a panacea, but there is little justification for ever increasing the patient 312 
burden. Though the rapid progression of outcomes research may provide computational 313 
models of comparison between measurements, in the immediate term, we would call for the 314 
clear, systematic evaluation of condition-specific elbow related rating systems, using well-315 
recognized methods such as the COSMIN checklist 
[36]
 or EMPRO tool 
[54]
.  Only then can 316 
clinicians and researchers make informed decisions on the appropriate tool for the elbow 317 
pathology and population of interest.     318 
 319 
 320 
 321 
 322 
 323 
 324 
 325 
 326 
 327 
Clinical Rating Systems in Elbow Research 
 
15 
 
References 328 
1. Ahmed S, Berzon RA, Revicki DA, Lenderking WR, Moinpour CM, Basch E, et al. The use 329 
of patient-reported outcomes (PRO) within comparative effectiveness research: implications for 330 
clinical practice and health care policy. Medical Care. 2012;50(12):1060-70. DOI: 331 
10.1097/MLR.0b013e318268aaff. 332 
2. Alonso J, Bartlett SJ, Rose M, Aaronson NK, Chaplin JE, Efficace F, et al. The case for an 333 
international patient-reported outcomes measurement information system (PROMIS®) initiative. 334 
Health and Quality of Life Outcomes. 2013;11(1):1-5 DOI: 10.1186/1477-7525-11-210. 335 
3. Altan L, Ercan I, Konur S. Reliability and validity of Turkish version of the patient rated 336 
tennis elbow evaluation. Rheumatology International. 2010;30(8):1049-54 DOI: 10.1007/s00296-009-337 
1101-6. 338 
4. Andrews JR, St Pierre RK, Carson Jr WG. Arthroscopy of the elbow. Clinics in Sports 339 
Medicine. 1986;5(4):653-62. 340 
5. Angst F, John M, Pap G, Mannion AF, Herren DB, Flury M, et al. Comprehensive assessment 341 
of clinical outcome and quality of life after total elbow arthroplasty. Arthritis & Rheumatism: 342 
Arthritis Care & Research. 2005;53(1):73-82 10p. 343 
6. Angst F, Goldhahn J, Drerup S, Kolling C, Aeschlimann A, Simmen BR, et al. 344 
Responsiveness of five outcome measurement instruments in total elbow arthroplasty. Arthritis Care 345 
Res (Hoboken). 2012;64(11):1749-55 DOI: 10.1002/acr.21744. 346 
7. Antuna S, Barco R. Essential Techniques in Elbow Surgery: Springer; 2016. ISBN 978-3-347 
319-31575-1 348 
8. Berwick D, Hiatt H, Janeway P, Smith R. An ethical code for everybody in health care. BMJ. 349 
1997;315(7123):1633-4. 350 
Clinical Rating Systems in Elbow Research 
 
16 
 
9. Black N, Burke L, Forrest CB, Sieberer UR, Ahmed S, Valderas J, et al. Patient-reported 351 
outcomes: pathways to better health, better services, and better societies. Quality of Life Research. 352 
2016;25(5):1103-12. DOI: 10.1007/s11136-015-1168-3 353 
10. Bren L. The importance of patient-reported outcomes... it's all about the patients. FDA 354 
consumer. 2006;40(6):26. 355 
11. Buchbinder R, Johnston RV, Barnsley L, Assendelft W, Bell SN, Smidt N. Surgery for lateral 356 
elbow pain. Cochrane Database Syst Rev. 2011;3(3). DOI: 10.1002/14651858.CD003525.pub2 357 
12. Buchbinder R, Maher C, Harris IA. Setting the research agenda for improving health care in 358 
musculoskeletal disorders. Nature Reviews Rheumatology. 2015;11(10):597-605 DOI: 359 
10.1038/nrrheum.2015.81. 360 
13. Cacchio A, Necozione S, MacDermid JC, Rompe JD, Maffulli N, di Orio F, et al. Cross-361 
cultural adaptation and measurement properties of the Italian version of the Patient-Rated Tennis 362 
Elbow Evaluation (PRTEE) questionnaire. Phys Ther. 2012;92(8):1036-45 DOI: 363 
10.2522/ptj.20110398. 364 
14. Caliandro P, La Torre G, Padua R, Giannini F, Padua L. Treatment for ulnar neuropathy at the 365 
elbow. Cochrane Database Syst Rev. 2011;2. DOI: 10.1002/14651858.CD006839.pub4 366 
15. Celik D, Atalar AC, Demirhan M, Dirican A. Translation, cultural adaptation, validity and 367 
reliability of the Turkish ASES questionnaire. Knee Surg Sports Traumatol Arthrosc. 368 
2013;21(9):2184-9 DOI: 10.1007/s00167-012-2183-3. 369 
16. Celik D. Psychometric properties of the Mayo Elbow Performance Score. Rheumatol Int. 370 
2015;35(6):1015-20 DOI: 10.1007/s00296-014-3201-1. 371 
17. Dawson J, Doll H, Boller I, Fitzpatrick R, Little C, Rees J, et al. Factors associated with 372 
satisfaction in patients undergoing elbow surgery: a prospective study. J Shoulder Elbow Surg. 373 
2010;19(5):635-44 DOI: 10.1016/j.jse.2010.02.003. 374 
Clinical Rating Systems in Elbow Research 
 
17 
 
18. Dawson J, Doll H, Fitzpatrick R, Jenkinson C, Carr AJ. The routine use of patient reported 375 
outcome measures in healthcare settings. BMJ. 2010;340:c186. DOI: 10.1038/tp.2016.61 376 
19. Dawson J, Doll H, Boller I, Fitzpatrick R, Little C, Rees J, et al. Specificity and 377 
responsiveness of patient-reported and clinician-rated outcome measures in the context of elbow 378 
surgery, comparing patients with and without rheumatoid arthritis. Orthop Traumatol-Sur. 379 
2012;98(6):652-8 DOI: 10.1016/j.otsr.2012.05.011. 380 
20. De Boer YA, Van Den Ende CHM, Eygendaal D, Jolie IMM, Hazes JMW, Rozing PM. 381 
Clinical reliability and validity of elbow functional assessment in rheumatoid arthritis. Journal of 382 
Rheumatology. 1999;26(9):1909-17 9p. 383 
21. de Boer YA, Hazes JM, Winia PC, Brand R, Rozing PM. Comparative responsiveness of four 384 
elbow scoring instruments in patients with rheumatoid arthritis. The Journal of Rheumatology. 385 
2001;28(12):2616-23. 386 
22. de Haan J, Goei H, Schep NW, Tuinebreijer WE, Patka P, den Hartog D. The reliability, 387 
validity and responsiveness of the Dutch version of the Oxford elbow score. J Orthop Surg Res. 388 
2011;6:39 DOI: 10.1186/1749-799X-6-39. 389 
23. Dellon AL, Hament W, Gittelshon A. Nonoperative management of cubital tunnel syndrome 390 
An 8‐year prospective study. Neurology. 1993;43(9):1673-. 391 
24. Devlin NJ, Appleby J. Getting the most out of PROMS. Putting health outcomes at the heart 392 
of NHS decision making London: King’s Fund. 2010. ISBN978 1 85717 591 2 393 
25. Franchignoni F, Vercelli S, Giordano A, Sartorio F, Bravini E, Ferriero G. Minimal clinically 394 
important difference of the disabilities of the arm, shoulder and hand outcome measure (DASH) and 395 
its shortened version (QuickDASH). Journal of Orthopaedic & Sports Physical Therapy. 396 
2014;44(1):30-9. DOI: 10.2519/jospt.2014.4893 397 
Clinical Rating Systems in Elbow Research 
 
18 
 
26. Gonçalves Bradley DC, Gibbons C, Ricci‐Cabello I, Bobrovitz NJ, Gibbons EJ, Kotzeva A, et 398 
al. Routine provision of information on patient‐reported outcome measures to healthcare providers 399 
and patients in clinical practice. The Cochrane Library. 2015. DOI: 10.1002/14651858.CD011589 400 
27. Gosling T, Blauth M, Lange T, Richter M, Bastian L, Krettek C. Outcome assessment after 401 
arthrolysis of the elbow. Arch Orthop Traum Su. 2004;124(4):232-6. DOI: 10.1007/s00402-003-402 
0524-x 403 
28. Hudak PL, Amadio PC, Bombardier C, Beaton D, Cole D, Davis A, et al. Development of an 404 
upper extremity outcome measure: the DASH (disabilities of the arm, shoulder, and hand). American 405 
Journal of Industrial Medicine. 1996;29(6):602-8. 406 
29. Janssen S, De Smet L. Responsiveness of the DASH questionnaire for surgically treated 407 
tennis elbow. Acta Chir Belg. 2008;108(5):583-5. DOI:10.1080/00015458.2008.11680290 408 
30. Longo UG, Franceschi F, Loppini M, Maffulli N, Denaro V. Rating systems for evaluation of 409 
the elbow. British Medical Bulletin. 2008;87:131-61 DOI: 10.1093/bmb/ldn023. 410 
31. MacDermid JC, Michlovitz SL. Examination of the elbow: Linking diagnosis, prognosis, and 411 
outcomes as a framework for maximizing therapy interventions. Journal of Hand Therapy. 412 
2006;19(2):82-97 DOI: 10.1197/j.jht.2006.02.018. 413 
32. Macdermid JC, Silbernagel KG. Outcome Evaluation in Tendinopathy: Foundations of 414 
Assessment and a Summary of Selected Measures. Journal of Orthopaedic & Sports Physical 415 
Therapy. 2015;45(11):950-64 DOI: doi:10.2519/jospt.2015.6054. 416 
33. Malay S, Chung KC, Grp SS. The minimal clinically important difference after simple 417 
decompression for ulnar neuropathy at the elbow. Journal of Hand Surgery-American Volume. 418 
2013;38(4):652-9. DOI: 10.1016/j.jhsa.2013.01.022 419 
34. Matar H, Ali A, Buckley S, Garlick N, Atkinson H. Surgical interventions for treating 420 
fractures of the olecranon (an elbow bone) in adults. Health. 2014. DOI: 421 
10.1002/14651858.CD010144.pub2 422 
Clinical Rating Systems in Elbow Research 
 
19 
 
35. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews 423 
and meta-analyses: the PRISMA statement. Annals of Internal Medicine. 2009;151(4):264-9. 424 
36. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN 425 
checklist for assessing the methodological quality of studies on measurement properties of health 426 
status measurement instruments: an international Delphi study. Qual Life Res. 2010;19 DOI: 427 
10.1007/s11136-010-9606-8. 428 
37. Morrey B, Adams R. Semiconstrained arthroplasty for the treatment of rheumatoid arthritis of 429 
the elbow. J Bone Joint Surg Am. 1992;74(4):479-90. 430 
38. Morrey BF. Fracture of the radial head. The elbow and its disorders 2nd ed Philadelphia: WB 431 
Saunders. 1993:383-404. 432 
39. Newcomer KL, Martinez-Silvestrini JA, Schaefer MP, Gay RE, Arendt KW. Sensitivity of 433 
the Patient-rated Forearm Evaluation Questionnaire in lateral epicondylitis. Journal of Hand Therapy. 434 
2005;18(4):400-73 8p. DOI: 10.1197/j.jht.2005.07.001 435 
40. NICE. National Institute for Healthcare and Clinical Excellence: Guide to the Methods of 436 
Technology Appraisal 20132013 [Available from: 437 
https://www.nice.org.uk/process/pmg9/chapter/foreword. 438 
41. Nilsson P, Baigi A, Marklund B, Mansson J. Cross-cultural adaptation and determination of 439 
the reliability and validity of PRTEE-S, a questionnaire for patients with lateral epicondylalgia, in a 440 
Swedish population. BMC Musculoskelet Disord. 2008;9:79 DOI: 10.1186/1471-2474-9-79. 441 
42. Osoba D, King M. Meaningful differences. Assessing quality of life in clinical trials. 442 
2005;2:243-57. ISBN: 9780198527695 443 
43. PROsettaStone. Linking Patient-Reported Outcome Measures. 2014. [Available from 444 
http://www.prosettastone.org/Pages/default.aspx] Last accessed 20/8/17 445 
44. Raven EEJ, Haverkamp D, Sierevelt IN, van Montfoort DO, Poll RG, Blankevoort L, et al. 446 
Construct validity and reliability of the disability of arm, shoulder and hand questionnaire for upper 447 
Clinical Rating Systems in Elbow Research 
 
20 
 
extremity complaints in rheumatoid arthritis. Journal of Rheumatology. 2008;35(12):2334-8 DOI: 448 
10.3899/jrheum.080067. 449 
45. Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, et al. ISOQOL 450 
recommends minimum standards for patient-reported outcome measures used in patient-centered 451 
outcomes and comparative effectiveness research. Quality of Life Research. 2013;22:1889-905. DOI: 452 
10.1007/s11136-012-0344-y 453 
46. Riedel K, Beaton DE. Update on the state of outcome measurement in total elbow 454 
arthroplasty research: identifying a need for consensus. J Bone Joint Surg Am. 2013;95(14):e97 1-8 455 
DOI: 10.2106/JBJS.K.01420. 456 
47. Rompe JD, Overend TJ, MacDermid JC. Validation of the Patient-rated Tennis Elbow 457 
Evaluation Questionnaire. Journal of Hand Therapy 2007;20(1):3-10; quiz 1 DOI: 458 
10.1197/j.jht.2006.10.003. 459 
48. Snyder CF, Jensen RE, Segal JB, Wu AW. Patient-reported outcomes (PROs): putting the 460 
patient perspective in patient-centered outcomes research. Medical Care. 2013;51(8 0 3):S73. DOI: 461 
10.1097/MLR.0b013e31829b1d84 462 
49. Sorensen AA, Howard D, Tan WH, Ketchersid J, Calfee RP. Minimal clinically important 463 
differences of 3 patient-rated outcomes instruments. The Journal of Hand Surgery. 2013;38(4):641-9. 464 
DOI: 10.1016/j.jhsa.2012.12.032 465 
50. Stasinopoulos D, Papadopoulos C, Antoniadou M, Nardi L. Greek adaptation and validation 466 
of the Patient-Rated Tennis Elbow Evaluation (PRTEE). J Hand Ther. 2015;28(3):286-90; quiz 91 467 
DOI: 10.1016/j.jht.2014.12.005. 468 
51. Sussmann PS, Simmen BR, Goldhahn J, Sculco TP. Challenges for large orthopaedic 469 
hospitals worldwide—an ISOC position statement. HSS journal. 2010;6(1):57-60. DOI: 470 
10.1007/s11420-009-9144-5 471 
Clinical Rating Systems in Elbow Research 
 
21 
 
52. The B, Reininga IH, El Moumni M, Eygendaal D. Elbow-specific clinical rating systems: 472 
extent of established validity, reliability, and responsiveness. J Shoulder Elbow Surg. 473 
2013;22(10):1380-94 DOI: 10.1016/j.jse.2013.04.013. 474 
53. Turchin DC, Beaton DE, Richards RR. Validity of observer-based aggregate scoring systems 475 
as descriptors of elbow pain, function, and disability. J Bone Joint Surg Am. 1998;80(2):154-62. 476 
54. Valderas JM, Ferrer M, Mendivil J, Garin O, Rajmil L, Herdman M, et al. Development of 477 
EMPRO: a tool for the standardized assessment of patient-reported outcome measures. Value Health. 478 
2008;11(4):700-8 DOI: 10.1111/j.1524-4733.2007.00309.x. 479 
55. van Ark M, Zwerver J, Diercks RL, van den Akker-Scheek I. Cross-cultural adaptation and 480 
reliability and validity of the Dutch Patient-Rated Tennis Elbow Evaluation (PRTEE-D). BMC 481 
Musculoskelet Disord. 2014;15:270 DOI: 10.1186/1471-2474-15-270. 482 
56. Vincent JI, MacDermid JC, King G, Grewal R. Psychometric evaluation of self-reported pain 483 
and disability measures for elbow pathologies. Journal of Hand Therapy. 2011;24(4):381-2 2p. DOI: 484 
http://dx.doi.org/10.1016/j.jht.2011.07.012 485 
57. Vincent JI, MacDermid JC, King GJ, Grewal R. Validity and sensitivity to change of patient-486 
reported pain and disability measures for elbow pathologies. Journal of Orthopaedic & Sports 487 
Physical Therapy. 2013;43(4):263-74. DOI: 10.2519/jospt.2013.4029 488 
58. Wu AW, Kharrazi H, Boulware LE, Snyder CF. Measure once, cut twice—adding patient-489 
reported outcome measures to the electronic health record for comparative effectiveness research. 490 
Journal of Clinical Epidemiology. 2013;66(8):S12-S20. DOI: 10.1016/j.jclinepi.2013.04.005 491 
59. Zimmerman NB, Kaye MB, Wilgis EFS, Zimmerman RM, Dubin NH. Are standardized 492 
patient self-reporting instruments applicable to the evaluation of ulnar neuropathy at the elbow? J 493 
Shoulder Elbow Surg. 2009;18(3):463-8. DOI: 10.1016/j.jse.2009.02.010 494 
 495 
 496 
Clinical Rating Systems in Elbow Research 
 
22 
 
Tables and Figures: 497 
 498 
Figure 1: PRISMA flowchart 499 
Figure 2: Number of studies published per year that report use of elbow/region-specific clinical rating 500 
systems. 501 
Figure 3: Proportional prevalence of the most common rating systems in articles since database 502 
inception, 2000 and 2010. 503 
Figure 4: Top five clinical rating systems in each pathology group. (MEPS=Mayo Elbow Performance 504 
Score, DASH=Disabilities of Arm Shoulder and Hand, QDASH=quick Disabilities of Arm Shoulder 505 
and Hand, ASES-e=American Shoulder and Elbow Society-elbow, PRTEE=Patient Reported Tennis 506 
Elbow Evaluation, OES=Oxford Elbow Score, HSS=Hospital for Special Surgery Score, 507 
KJOC=Kerlan Jobe Orthopaedic Clinic overhead athlete score) 508 
Table 1: Change in use of clinical rating system over time (no. of articles using a clinical rating 509 
system (percentage of articles using clinical rating system).   510 
Table 2: Geographical use of clinical rating systems (no. of articles using a clinical rating system and 511 
percentage of articles using clinical rating system).  512 
Appendix 1: Medline Search strategy (run 1/5/2017) 513 
Appendix 2: List or Clinical Ratings Systems Identified – Ordered by Prevalence of Use 514 
 
Figure 1  
 
 
Figure (No.1)
 
Figure 1  
 
Figure (No.2)
 
Figure 1  
 
Figure (No.3)
 Figure 1   
 
Figure (No.4)
  
  
Arthroplasty Tendinopathy Trauma  
Inception   Since 
2000 
  Since 
2010 
  Inception   Since 
2000 
  Since 
2010 
  Inception   Since 
2000 
  Since 
2010 
  
Articles (n) 151  %  133  % 74  % 198  % 190  % 128  % 405  % 365  % 128  % 
Total Outcomes 
(n) 
199  180   109   244  235   162   621  580   162   
MEPS 124 82.1 116 87.2 66 89.2 26 13.1 25 13.2 22 17.2 270 66.7 270 74.0 200 74.6 
DASH 25 16.6 24 18.0 17 23.0 61 30.8 61 32.1 46 35.9 132 32.6 132 36.2 100 37.3 
MORREY 5 3.3 3 2.3 1 1.4             92 22.7 85 23.3 46 17.2 
QDASH 10 6.6 10 7.5 9 12.2 19 9.6 19 10.0 19 14.8 28 6.9 28 7.7 27 10.1 
ASES-e                         21 5.2 21 5.8 12 4.5 
PRTEE             46 23.2 46 24.2 39 30.5             
OES 6 4.0 6 4.5 6 8.1                         
Roles+Maudsley             14 7.1 13 6.8 2 1.6             
Nirschl              17 8.6 16 8.4 10 7.8             
Table 1  
 
Tables (No. 1)
  North America Europe Rest of the World 
Total Arthroplasty Tendinopathy Trauma Total Arthroplasty Tendinopathy Trauma Total Arthroplasty Tendinopathy Trauma 
Articles (n) 264  % 50  % 47 % 86 % 370 % 76 % 66 % 151 % 319 % 26 % 77 % 155 % 
Total No. of 
Outcomes (n) 
370   58   57   140   558   109   78   254   411   32   98   204   
MEPS 117 44.3 37 74.0 8 17.0 47 54.7 198 53.5 63 82.9 6 9.1 101 66.9 195 61.1 25 96.2 13 16.9 114 73.5 
DASH 97 36.7 6 12.0 16 34.0 43 50.0 109 29.5 15 19.7 19 28.8 50 33.1 73 22.9 3 11.5 24 31.2 35 22.6 
MORREY 20 7.6 1 2.0     16 18.6 59 15.9 3 3.9     42 27.8 35 11.0 1 3.8     31 20.0 
QDASH 15 5.7     2 4.3 4 4.7 22 5.9 11 14.5 5 7.6 15 9.9 18 5.6 1 3.8 9 11.7 5 3.2 
ASES-e 23 8.7 2 4.0     12 14.0 10 2.7             5 1.6         5 3.2 
PRTEE 9 3.4     9 19.1     10 2.7     9 13.6     26 8.2     21 27.3     
OES 4 1.5             29 7.8 6 7.9     15 9.9 3 0.9             
HSS 2 0.8 1 2.0         6 1.6             6 1.9             
Roles+ 
Maudsley 
1 0.4             11 3.0     10 15.2     3 0.9             
Nirschl  5 1.9     6 12.8     3 0.8     3 4.5     8 2.5     8 10.4     
Table 1
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